Stereotactic body radiation therapy use for high risk prostate cancer in the United States

被引：3
|
作者：
Patel, Sagar A. [1 ]
Switchenko, Jeffrey M. [2 ]
Kishan, Amar U. [3 ]
Jani, Ashesh B. [1 ]
Royce, Trevor J. [4 ]
Fischer-Valuck, Benjamin W. [1 ]
机构：
[1] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA
[4] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2021年 / 24卷 / 02期
关键词：
ANDROGEN SUPPRESSION;
D O I：
10.1038/s41391-020-00300-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：578 / 581
页数：4
相关论文
共 50 条
  • [1] Stereotactic body radiation therapy use for high risk prostate cancer in the United States
    Sagar A. Patel
    Jeffrey M. Switchenko
    Amar U. Kishan
    Ashesh B. Jani
    Trevor J. Royce
    Benjamin W. Fischer-Valuck
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 578 - 581
  • [2] Stereotactic body radiation therapy for high-risk prostate cancer: Not ready
    Royce, Trevor J.
    Chen, Ronald C.
    PRACTICAL RADIATION ONCOLOGY, 2018, 8 (03) : 203 - 205
  • [3] Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012
    Bledsoe, T. J.
    Rutter, C. E.
    Corso, C. D.
    Aneja, S.
    Lester-Coll, N. H.
    Wang, E. H.
    Potosky, A.
    Gross, C. P.
    Yu, J. B.
    Park, H. S. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E359 - E359
  • [4] Stereotactic body radiation therapy for prostate cancer
    Ishiyama, Hiromichi
    Teh, Bin S.
    Lo, Simon S.
    Mathews, Thomas
    Blanco, Angel
    Amato, Robert
    Ellis, Rodney J.
    Mayr, Nina A.
    Paulino, Arnold C.
    Xu, Bo
    Butler, Brian E.
    FUTURE ONCOLOGY, 2011, 7 (09) : 1077 - 1086
  • [5] Prostate cancer therapy with stereotactic body radiation therapy
    Pawlicki, Todd
    Cotrutz, Cristian
    King, Christopher
    IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 2007, 40 : 395 - 406
  • [6] Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States
    Mahase, Sean S.
    D'Angelo, Debra
    Kang, Josephine
    Hu, Jim C.
    Barbieri, Christopher E.
    Nagar, Himanshu
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [7] Hypofractionated stereotactic body radiation therapy in low-risk prostate cancer
    Kim, H. J.
    Kim, W. C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S90 - S91
  • [8] Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer
    Haas, J.
    Katz, A. E.
    Santoro, M.
    Ashley, R.
    Mucciolo, R.
    Kessaris, D.
    Andrews, J.
    Clancey, O.
    Sanchez, A.
    Witten, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S361 - S361
  • [9] Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
    Muldermans, Jonathan L.
    Romak, Lindsay B.
    Kwon, Eugene D.
    Park, Sean S.
    Olivier, Kenneth R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02): : 696 - 702
  • [10] Stereotactic Body Radiation Therapy for Localized Prostate Cancer
    Lischalk, Jonathan W.
    Kaplan, Irving D.
    Collins, Sean P.
    CANCER JOURNAL, 2016, 22 (04): : 307 - 313
12345